80.68
price down icon0.28%   -0.23
after-market After Hours: 80.71 0.03 +0.04%
loading
Medtronic Plc stock is traded at $80.68, with a volume of 10.32M. It is down -0.28% in the last 24 hours and down -3.67% over the past month. One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$80.91
Open:
$80.62
24h Volume:
10.32M
Relative Volume:
1.42
Market Cap:
$103.48B
Revenue:
$33.20B
Net Income/Loss:
$4.26B
P/E Ratio:
24.52
EPS:
3.29
Net Cash Flow:
$5.47B
1W Performance:
-6.66%
1M Performance:
-3.67%
6M Performance:
-6.41%
1Y Performance:
-0.86%
1-Day Range:
Value
$79.93
$80.81
1-Week Range:
Value
$79.93
$88.28
52-Week Range:
Value
$75.96
$96.25

Medtronic Plc Stock (MDT) Company Profile

Name
Name
Medtronic Plc
Name
Phone
01135314381700
Name
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Name
Employee
95,000
Name
Twitter
@Medtronic
Name
Next Earnings Date
2025-02-18
Name
Latest SEC Filings
Name
MDT's Discussions on Twitter

Compare MDT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
MDT
Medtronic Plc
80.68 110.39B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
ABT
Abbott Laboratories
131.30 232.01B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.50 155.13B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
376.62 149.89B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
EW
Edwards Lifesciences Corp
74.99 45.10B 5.54B 4.18B 623.10M 7.00

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-04-25 Upgrade Citigroup Neutral → Buy
Oct-10-24 Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-21-24 Reiterated Oppenheimer Perform
Aug-15-24 Upgrade UBS Sell → Neutral
Aug-14-24 Downgrade Stifel Buy → Hold
May-30-24 Initiated Goldman Sell
Jul-19-23 Initiated Robert W. Baird Neutral
Jun-30-23 Initiated CL King Buy
May-30-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-24-23 Upgrade Wells Fargo Equal Weight → Overweight
Mar-29-23 Downgrade UBS Buy → Sell
Jan-09-23 Downgrade RBC Capital Mkts Outperform → Sector Perform
Nov-23-22 Downgrade Citigroup Buy → Neutral
Nov-23-22 Downgrade Oppenheimer Outperform → Perform
Nov-16-22 Downgrade Deutsche Bank Buy → Hold
Oct-18-22 Initiated Barclays Equal Weight
Oct-13-22 Initiated Mizuho Buy
Oct-12-22 Initiated Jefferies Hold
Aug-24-22 Downgrade Raymond James Outperform → Mkt Perform
Jul-06-22 Initiated Wolfe Research Underperform
Jun-01-22 Downgrade Atlantic Equities Overweight → Neutral
May-27-22 Downgrade Needham Buy → Hold
Apr-13-22 Downgrade Truist Buy → Hold
Mar-02-22 Resumed BofA Securities Buy
Jan-10-22 Downgrade BTIG Research Buy → Neutral
Jan-07-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-04-22 Downgrade Piper Sandler Overweight → Neutral
Dec-17-21 Downgrade JP Morgan Overweight → Neutral
Dec-16-21 Downgrade Wells Fargo Overweight → Equal Weight
Dec-10-21 Initiated RBC Capital Mkts Outperform
Jun-10-21 Resumed Cowen Outperform
May-25-21 Initiated Barclays Equal Weight
Apr-15-21 Initiated Atlantic Equities Overweight
Dec-15-20 Upgrade Goldman Sell → Neutral
Dec-15-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-08-20 Upgrade Bernstein Mkt Perform → Outperform
Oct-08-20 Upgrade Stifel Hold → Buy
Sep-11-20 Initiated Wolfe Research Peer Perform
May-14-20 Downgrade DZ Bank Buy → Hold
Mar-30-20 Downgrade Needham Strong Buy → Buy
Mar-25-20 Upgrade DZ Bank Hold → Buy
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Sell
Jan-08-20 Initiated SunTrust Buy
Jan-02-20 Upgrade Guggenheim Neutral → Buy
Jun-05-19 Upgrade Wells Fargo Market Perform → Outperform
Feb-04-19 Reiterated Needham Strong Buy
Jan-03-19 Initiated Deutsche Bank Buy
Jan-02-19 Downgrade Citigroup Buy → Neutral
Dec-19-18 Upgrade JP Morgan Neutral → Overweight
Nov-28-18 Initiated UBS Buy
Oct-16-18 Initiated Barclays Overweight
Aug-27-18 Reiterated Argus Buy
View All

Medtronic Plc Stock (MDT) Latest News

pulisher
10:26 AM

Redburn Atlantic Adjusts Price Target on Medtronic to $101 From $104 - marketscreener.com

10:26 AM
pulisher
08:55 AM

JPMorgan Adjusts Medtronic Price Target to $87 From $95 - marketscreener.com

08:55 AM
pulisher
07:48 AM

Jim Cramer on Medtronic (MDT): “I Like This Medical Device Powerhouse” - Insider Monkey

07:48 AM
pulisher
05:52 AM

Blood Glucose Monitoring (BGM) Devices Market Report 2025: Hospitals Lead in Blood Glucose Monitoring Device Usage, Home Care Grows Fastest - GlobeNewswire Inc.

05:52 AM
pulisher
05:48 AM

Endoscopy Devices Global Market Overview 2021-2030 with Forecasts 2024-2030 - GlobeNewswire Inc.

05:48 AM
pulisher
May 22, 2025

Medtronic to separate diabetes business following recent struggles - MSN

May 22, 2025
pulisher
May 22, 2025

Medtronic Announces Separation From Diabetes Business, CEO Says it’s “In a Really Good Spot” - Insider Monkey

May 22, 2025
pulisher
May 22, 2025

Medtronic has a new Cardiovascular, CST leaders after longtime exec departs - MassDevice

May 22, 2025
pulisher
May 22, 2025

TD Cowen Keeps a Buy on Medtronic (MDT) After Better Growth in Q4 - Insider Monkey

May 22, 2025
pulisher
May 22, 2025

Medtronic PLC stock underperforms Thursday when compared to competitors - MarketWatch

May 22, 2025
pulisher
May 22, 2025

Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better? - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Global Foley Catheters Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight - GlobeNewswire Inc.

May 22, 2025
pulisher
May 22, 2025

MDT: RBC Capital Lowers Price Target for Medtronic | MDT Stock N - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Medtronic (MDT) Stock Price Target Lowered by Mizuho Analyst | M - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Medtronic inks expanded distro deal for multi-parameter wearable vital sign monitor - MassDevice

May 22, 2025
pulisher
May 22, 2025

Medtronic's Strong Q4 Performance Sets The Stage For Future Growth - Finimize

May 22, 2025
pulisher
May 22, 2025

Medtronic (MDT) Price Target Lowered by Baird Analyst | MDT Stoc - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Medtronic Cardiovascular Strength Drives Fiscal Q4 Beat, RBC Says - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Why Medtronic plans to spin out its diabetes business - MedTech Dive

May 22, 2025
pulisher
May 22, 2025

July 3rd Options Now Available For Medtronic (MDT) - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon - MassDevice

May 22, 2025
pulisher
May 22, 2025

Medtronic (MDT) Price Target Lowered by RBC Capital Amid Growth Investments | MDT Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Truist Adjusts Price Target on Medtronic to $92 From $90, Maintains Hold Rating - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Oppenheimer Adjusts Medtronic Price Target to $92 From $94 - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Medtronic (MDT) Price Target Lowered but Growth Potential Remains Strong | MDT Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Medtronic plc (NYSE:MDT) Q4 2025 Earnings Call Transcript - MSN

May 22, 2025
pulisher
May 22, 2025

Medtronic (MDT) Sees Price Target Reduced by Baird | MDT Stock N - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Medtronic to split diabetes business into separate entity, targets IPO - Medical Device Network

May 22, 2025
pulisher
May 22, 2025

Needham Reiterates 'Hold' Rating on Medtronic (MDT) | MDT Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Baird Adjusts Price Target on Medtronic to $92 From $94, Maintains Neutral Rating - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Medtronic still hiding behind its status as a dividend aristocrat - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Medtronic announces intent to separate diabetes business - BioSpectrum Asia

May 22, 2025
pulisher
May 22, 2025

Medtronic : expands its Acute Care & Monitoring portfolio in Europe with a new distribution agreement for the Corsano™ multi-parameter wearable - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Medtronic PLC (MDT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Moves - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Medtronic PLC (MDT) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Medtronic plc. (MDT) Stock Forecasts - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Medtronic Reports Strong FY25 Results and Dividend Increase - TipRanks

May 22, 2025
pulisher
May 21, 2025

Medtronic: Fiscal Q4 Earnings Snapshot - Norwalk Hour

May 21, 2025
pulisher
May 21, 2025

Medtronic to Split Off Diabetes Unit as Tariffs Hit Earnings - MSN

May 21, 2025
pulisher
May 21, 2025

Medtronic aims to sweeten appeal by unloading diabetes unit - BioWorld MedTech

May 21, 2025
pulisher
May 21, 2025

Evercore ISI maintains Outperform on Medtronic, keeps $103 target By Investing.com - Investing.com UK

May 21, 2025
pulisher
May 21, 2025

Evercore ISI Removes Medtronic, Inc. (MDT) from TAP List - StreetInsider

May 21, 2025
pulisher
May 21, 2025

Medtronic stock price target cut to $103 by Evercore ISI - Investing.com UK

May 21, 2025
pulisher
May 21, 2025

Medtronic plc Announces Cash Dividend for the First Quarter of Fiscal Year 2026, Payable on July 11, 2025 - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Citi cuts Medtronic price target to $98, maintains buy rating By Investing.com - Investing.com UK

May 21, 2025
pulisher
May 21, 2025

Medtronic (MDT) Announces Diabetes Business Separation and Growt - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Medtronic earns CE mark for redo TAVI procedure - MassDevice

May 21, 2025
pulisher
May 21, 2025

Medtronic plc (NYSE: MDT) Stock: Dips Despite Q425 Beat as FY26 Forecast Disappoints - CoinCentral

May 21, 2025
pulisher
May 21, 2025

Medtronic outlines 5% organic revenue growth target and diabetes business separation ahead of FY26 - MSN

May 21, 2025
pulisher
May 21, 2025

Medtronic, Inc. (MDT) PT Lowered to $98 at Citi - StreetInsider

May 21, 2025
pulisher
May 21, 2025

Medtronic plc agreed to Spin-Off New Diabetes Company. - marketscreener.com

May 21, 2025

Medtronic Plc Stock (MDT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices SYK
$376.62
price down icon 0.44%
medical_devices BSX
$104.50
price up icon 0.00%
medical_devices EW
$74.99
price up icon 0.27%
$84.51
price down icon 0.38%
$69.16
price down icon 0.40%
Cap:     |  Volume (24h):